Park Ha Biological Technology is trading 7.8% down today at $0.33 as the stock faces continued pressure from recent dilutive equity offerings.
- The company recently closed a public offering of 21.87 million units priced at $0.112 per unit, significantly below previous trading levels.
- Shares previously fell approximately 26.9% following the announcement, reflecting investor anxiety regarding equity dilution.
- Ongoing concerns regarding balance-sheet risk and the impact of the capital raise continue to weigh on the company's market valuation.